D-dimer as a significant marker of deep vein thrombosis in patients with subclinical or overt Cushing’s syndrome-Reference-Cited by-同舟云学术

D-dimer as a significant marker of deep vein thrombosis in patients with subclinical or overt Cushing’s syndrome

Published:2014 Issue:10 Volume:61 Page:1003-1010
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Fukuoka Hidenori¹,Takeuchi Takehito¹,Matsumoto Ryusaku²,Bando Hironori²,Suda Kentaro²,Nishizawa Hitoshi¹,Takahashi Michiko¹,Hirota Yushi¹,Iguchi Genzo¹,Takahashi Yutaka²

Affiliation:

1. Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan

2. Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/61/10/61_EJ14-0102/_pdf

Reference34 articles.

1. 1. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, et al. (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88: 5593-5602.

2. 2. Stuijver DJ, van Zaane B, Feelders RA, Debeij J, Cannegieter SC, et al. (2011) Incidence of venous thromboembolism in patients with Cushing’s syndrome: a multicenter cohort study. J Clin Endocrinol Metab 96: 3525-3532.

3. 3. Van Zaane B, Nur E, Squizzato A, Dekkers OM, Twickler MT, et al. (2009) Hypercoagulable state in Cushing’s syndrome: a systematic review. J Clin Endocrinol Metab 94: 2743-2750.

4. 4. Trementino L, Arnaldi G, Appolloni G, Daidone V, Scaroni C, et al. (2010) Coagulopathy in Cushing’s syndrome. Neuroendocrinology 92 Suppl 1: 55-59.

5. 5. Sjoberg HE, Blomback M, Granberg PO (1976) Thromboembolic complications, heparin treatment in increase in coagulation factors in Cushing’s syndrome. Acta Med Scand 199: 95-98.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daytime plasma cortisol and cortisol response to dexamethasone suppression are associated with a prothrombotic state in hypertension;Frontiers in Endocrinology;2024-05-21

2. The thrombotic risk in Cushing’s syndrome—questions, answers, and the algorithm to consider in its assessment: part I—thrombotic risk not related to surgery;Frontiers in Endocrinology;2024-03-11

3. Statins and Hemostasis: Therapeutic Potential Based on Clinical Evidence;Advances in Experimental Medicine and Biology;2023

4. Aggressive Cushing’s Disease: Molecular Pathology and Its Therapeutic Approach;Frontiers in Endocrinology;2021-06-16

5. Hypercoagulability in Cushing’s syndrome: From arterial to venous disease;Best Practice & Research Clinical Endocrinology & Metabolism;2021-03